These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 20889904)

  • 1. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.
    Mallia P; Message SD; Gielen V; Contoli M; Gray K; Kebadze T; Aniscenko J; Laza-Stanca V; Edwards MR; Slater L; Papi A; Stanciu LA; Kon OM; Johnson M; Johnston SL
    Am J Respir Crit Care Med; 2011 Mar; 183(6):734-42. PubMed ID: 20889904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD.
    Footitt J; Mallia P; Durham AL; Ho WE; Trujillo-Torralbo MB; Telcian AG; Del Rosario A; Chang C; Peh HY; Kebadze T; Aniscenko J; Stanciu L; Essilfie-Quaye S; Ito K; Barnes PJ; Elkin SL; Kon OM; Wong WS; Adcock IM; Johnston SL
    Chest; 2016 Jan; 149(1):62-73. PubMed ID: 25790167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease.
    Mallia P; Footitt J; Sotero R; Jepson A; Contoli M; Trujillo-Torralbo MB; Kebadze T; Aniscenko J; Oleszkiewicz G; Gray K; Message SD; Ito K; Barnes PJ; Adcock IM; Papi A; Stanciu LA; Elkin SL; Kon OM; Johnson M; Johnston SL
    Am J Respir Crit Care Med; 2012 Dec; 186(11):1117-24. PubMed ID: 23024024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD.
    Zhu J; Mallia P; Footitt J; Qiu Y; Message SD; Kebadze T; Aniscenko J; Barnes PJ; Adcock IM; Kon OM; Johnson M; Contoli M; Stanciu LA; Papi A; Jeffery PK; Johnston SL
    J Allergy Clin Immunol; 2020 Oct; 146(4):840-850.e7. PubMed ID: 32283204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease.
    Mallia P; Webber J; Gill SK; Trujillo-Torralbo MB; Calderazzo MA; Finney L; Bakhsoliani E; Farne H; Singanayagam A; Footitt J; Hewitt R; Kebadze T; Aniscenko J; Padmanaban V; Molyneaux PL; Adcock IM; Barnes PJ; Ito K; Elkin SL; Kon OM; Cookson WO; Moffat MF; Johnston SL; Tregoning JS
    J Allergy Clin Immunol; 2018 Sep; 142(3):815-823.e6. PubMed ID: 29310905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease.
    Mallia P; Message SD; Contoli M; Gray K; Telcian A; Laza-Stanca V; Papi A; Stanciu LA; Elkin S; Kon OM; Johnson M; Johnston SL
    Respir Med; 2014 Jan; 108(1):78-85. PubMed ID: 24099891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD.
    Quint JK; Donaldson GC; Goldring JJ; Baghai-Ravary R; Hurst JR; Wedzicha JA
    Chest; 2010 Apr; 137(4):812-22. PubMed ID: 19837822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral immunity is impaired in COPD patients with frequent exacerbations.
    Singanayagam A; Loo SL; Calderazzo M; Finney LJ; Trujillo Torralbo MB; Bakhsoliani E; Girkin J; Veerati P; Pathinayake PS; Nichol KS; Reid A; Footitt J; Wark PAB; Grainge CL; Johnston SL; Bartlett NW; Mallia P
    Am J Physiol Lung Cell Mol Physiol; 2019 Dec; 317(6):L893-L903. PubMed ID: 31513433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An experimental model of rhinovirus induced chronic obstructive pulmonary disease exacerbations: a pilot study.
    Mallia P; Message SD; Kebadze T; Parker HL; Kon OM; Johnston SL
    Respir Res; 2006 Sep; 7(1):116. PubMed ID: 16956406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental rhinovirus infection in COPD: implications for antiviral therapies.
    Gunawardana N; Finney L; Johnston SL; Mallia P
    Antiviral Res; 2014 Feb; 102():95-105. PubMed ID: 24370732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.
    Wilkinson TMA; Hurst JR; Perera WR; Wilks M; Donaldson GC; Wedzicha JA
    Chest; 2006 Feb; 129(2):317-324. PubMed ID: 16478847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.
    Molyneaux PL; Mallia P; Cox MJ; Footitt J; Willis-Owen SA; Homola D; Trujillo-Torralbo MB; Elkin S; Kon OM; Cookson WO; Moffatt MF; Johnston SL
    Am J Respir Crit Care Med; 2013 Nov; 188(10):1224-31. PubMed ID: 23992479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human rhinovirus model of chronic obstructive pulmonary disease exacerbations.
    Contoli M; Caramori G; Mallia P; Papi A; Johnston SL
    Contrib Microbiol; 2007; 14():101-112. PubMed ID: 17684335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease.
    Singh M; Lee SH; Porter P; Xu C; Ohno A; Atmar RL; Greenberg SB; Bandi V; Gern J; Amineva S; Aminev A; Skern T; Smithwick P; Perusich S; Barrow N; Roberts L; Corry DB; Kheradmand F
    J Allergy Clin Immunol; 2010 Jun; 125(6):1369-1378.e2. PubMed ID: 20430426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation.
    Denlinger LC; Sorkness RL; Lee WM; Evans MD; Wolff MJ; Mathur SK; Crisafi GM; Gaworski KL; Pappas TE; Vrtis RF; Kelly EA; Gern JE; Jarjour NN
    Am J Respir Crit Care Med; 2011 Nov; 184(9):1007-14. PubMed ID: 21816938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human rhinovirus infection during naturally occurring COPD exacerbations.
    George SN; Garcha DS; Mackay AJ; Patel AR; Singh R; Sapsford RJ; Donaldson GC; Wedzicha JA
    Eur Respir J; 2014 Jul; 44(1):87-96. PubMed ID: 24627537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human rhinovirus infection and COPD: role in exacerbations and potential for therapeutic targets.
    Cafferkey J; Coultas JA; Mallia P
    Expert Rev Respir Med; 2020 Aug; 14(8):777-789. PubMed ID: 32498634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the detection rate and load of rhinovirus in nasal versus lower airway samples from patients with chronic obstructive pulmonary disease].
    Liao H; Chen R; Guan W; Yang Z; Liu W; Zhou R; Zhong N
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jan; 37(1):21-3. PubMed ID: 24694969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease.
    Seemungal TA; Harper-Owen R; Bhowmik A; Jeffries DJ; Wedzicha JA
    Eur Respir J; 2000 Oct; 16(4):677-83. PubMed ID: 11106212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.